Начало › Остра миелоидна левкемия › Мичиган › Ann Arbor
Клинични проучвания за Остра миелоидна левкемия в Ann Arbor, MI
17 проучвания за Остра миелоидна левкемия търсят участници в обекти в и около Ann Arbor (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 мили
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · на 18 мили
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Набиране на участнициФаза 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 мили
- и още 1
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Набиране на участнициФаза 1
- C S Mott Children's Hospital, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- и още 4
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 мили
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · на 18 мили
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Набиране на участнициФаза 3
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · на 7 мили
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 мили
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · на 18 мили
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 мили
- и още 1
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 мили
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 мили
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · на 18 мили
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Набиране на участнициФаза 3
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Набиране на участнициФаза 3
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Набиране на участнициФаза 1/2
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Набиране на участнициФаза 3
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Набиране на участнициФаза 3
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Набиране на участнициНаблюдателно проучване
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Набиране на участнициФаза 1
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Набиране на участнициФаза 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Проучвания за Остра миелоидна левкемия в други градове
- Houston, TX85 проучвания
- New York City, NY51 проучвания
- Boston, MA44 проучвания
- Seattle, WA41 проучвания
- Baldwin Park, CA40 проучвания
- Columbus, OH35 проучвания
- Philadelphia, PA34 проучвания
- Durham, NC33 проучвания
- Atlanta, GA31 проучвания
- Tampa, FL29 проучвания
- Chicago, IL26 проучвания
- Portland, OR25 проучвания
Други проучвания в Ann Arbor
- Рак на гърдата27 проучвания
- Рак на простатата27 проучвания
- Рак на белия дроб с недребноклетъчен тип26 проучвания
- Рак (всички видове)25 проучвания
- Рак на белия дроб23 проучвания
- Колоректален рак23 проучвания
- Сърдечна недостатъчност22 проучвания
- Сърдечно-съдово заболяване16 проучвания
- Рак на панкреаса14 проучвания
- Меланом12 проучвания
- Инсульт12 проучвания
- Плоскоклетъчен карцином на главата и шията12 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.